Home » Topics » Regulatory » Patents

Patents
RSS

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Modulators of muscarinic receptors claimed by Lilly for AD, psychosis

Jan. 15, 1998

Phthalazine AMPA receptor antagonists claimed by Schering AG

Jan. 15, 1998

Prodrugs of COX-2 inhibitors prepared at Searle

Jan. 15, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Texas Biotechnology prepares new endothelin modulators

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.